|
1
|
Fan X, Li Y, Shan X, You G, Wu Z, Li Z,
Qiao H and Jiang T: Seizures at presentation are correlated with
better survival outcomes in adult diffuse glioma: A systematic
review and meta-analysis. Seizure. 59:16–23. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sun X, Chen Y, Zhao H, Qiao G, Liu M,
Zhang C, Cui D and Ma L: Dual-modified cationic liposomes loaded
with paclitaxel and survivin siRNA for targeted imaging and therapy
of cancer stem cells in brain glioma. Drug Deliv. 25:1718–1727.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bastiancich C, Bianco J, Vanvarenberg K,
Ucakar B, Joudiou N, Gallez B, Bastiat G, Lagarce F, Préat V and
Danhier F: Injectable nanomedicine hydrogel for local chemotherapy
of glioblastoma after surgical resection. J Control Release.
264:45–54. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jiapaer S, Furuta T, Tanaka S, Kitabayashi
T and Nakada M: Potential Strategies Overcoming the Temozolomide
Resistance for Glioblastoma. Neurol Med Chir (Tokyo). 58:405–421.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sakamoto D, Takagi T, Fujita M, Omura S,
Yoshida Y, Iida T and Yoshimura S: Basic Gene Expression
Characteristics of Glioma Stem Cells and Human Glioblastoma.
Anticancer Res. 39:597–607. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Liebelt BD, Shingu T, Zhou X, Ren J, Shin
SA and Hu J: Glioma stem cells: Signaling, microenvironment, and
therapy. Stem Cells Int. 2016(7849890)2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Seyfried TN, Flores R, Poff AM, D'Agostino
DP and Mukherjee P: Metabolic therapy: A new paradigm for managing
malignant brain cancer. Cancer Lett. 356A:289–300. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Nakano I: Stem cell signature in
glioblastoma: Therapeutic development for a moving target. J
Neurosurg. 122:324–330. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Codrici E, Enciu AM, Popescu ID, Mihai S
and Tanase C: Glioma Stem Cells and Their Microenvironments:
Providers of Challenging Therapeutic Targets. Stem Cells Int.
2016(5728438)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shokoohinia Y, Jafari F, Mohammadi Z,
Bazvandi L, Hosseinzadeh L, Chow N, Bhattacharyya P, Farzaei MH,
Farooqi AA, Nabavi SM, et al: Potential Anticancer Properties of
Osthol: A Comprehensive Mechanistic Review. Nutrients. 10:36–51.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gao C, He XF, Xu QR, Xu YJ and Shen J:
Sevoflurane downregulates insulin-like growth factor-1 to inhibit
cell proliferation, invasion and trigger apoptosis in glioma
through the PI3K/AKT signaling pathway. Anticancer Drugs.
30(e0744)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Eissa IR, Bustos-Villalobos I, Ichinose T,
Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W,
Tanaka M, et al: The Current Status and Future Prospects of
Oncolytic Viruses in Clinical Trials against Melanoma, Glioma,
Pancreatic, and Breast Cancers. Cancers (Basel).
10(E356)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shen X, Liu X, Wan S, Fan X, He H, Wei R,
Pu W, Peng Y and Wang C: Discovery of coumarin as microtubule
affinity-regulating kinase 4 inhibitor that sensitize
hepatocellular carcinoma to paclitaxel. Front Chem.
7(366)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Barbato L, Bocchetti M, Di Biase A and
Regad T: Cancer stem cells and targeting strategies. Cells. 8:1–19.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Seano G: Targeting the perivascular niche
in brain tumors. Curr Opin Oncol. 30:54–60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Katayama R, Sakashita T, Yanagitani N,
Ninomiya H, Horiike A, Friboulet L, Gainor JF, Motoi N, Dobashi A,
Sakata S, et al: P-glycoprotein Mediates Ceritinib Resistance in
Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer.
EBio Medicine. 12:54–66. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hossain M, Banik NL and Ray SK:
Synergistic anti-cancer mechanisms of curcumin and paclitaxel for
growth inhibition of human brain tumor stem cells and LN18 and
U138MG cells. Neurochem Int. 61:1102–1113. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F,
Feng C, Xie Y, Sha X and Fang X: Nanoparticles of 2-deoxy-D-glucose
functionalized poly(ethylene glycol)-co-poly(trimethylene
carbonate) for dual-targeted drug delivery in glioma treatment.
Biomaterials. 35:518–529. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ancey PB, Contat C and Meylan E: Glucose
transporters in cancer - from tumor cells to the tumor
microenvironment. FEBS J. 285:2926–2943. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dacevic MP, Tasic JS, Pejanovic VM, Segal
MB, Ugliesic-Kilibarda DD, Isakovic AJ, Begley DJ, Rakic LM and
Redzic ZB: The linkage of glucose to tiazofurin decreases in vitro
uptake into rat glioma C6 cells. J Drug Target. 10:633–636.
2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Oh S, Kim H, Nam K and Shin I: Glut1
promotes cell proliferation, migration and invasion by regulating
epidermal growth factor receptor and integrin signaling in
triple-negative breast cancer cells. BMB Rep. 50:132–137.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Madunić IV, Madunić J, Breljak D, Karaica
D and Sabolić I: Sodium-glucose cotransporters: New targets of
cancer therapy? Arh Hig Rada Toksikol. 69:278–285. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jin X, Su H, Ding G, Sun Z and Li Z:
Exposure to ambient fine particles causes abnormal energy
metabolism and ATP decrease in lung tissues. Chemosphere.
224:29–38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ma Z, Cui X, Lu L, Chen G, Yang Y, Hu Y,
Lu Y, Cao Z, Wang Y and Wang X: Exosomes from glioma cells induce a
tumor-like phenotype in mesenchymal stem cells by activating
glycolysis. Stem Cell Res Ther. 10(60)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tech K, Tikunov AP, Farooq H, Morrissy AS,
Meidinger J, Fish T, Green SC, Liu H, Li Y, Mungall AJ, et al:
Pyruvate kinase inhibits proliferation during postnatal cerebellar
neurogenesis and suppresses medulloblastoma formation. Cancer Res.
77:3217–3230. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miao P, Sheng S, Sun X, Liu J and Huang G:
Lactate dehydrogenase A in cancer: A promising target for diagnosis
and therapy. IUBMB Life. 65:904–910. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Xintaropoulou C, Ward C, Wise A,
Queckborner S, Turnbull A, Michie CO, Williams ARW, Rye T, Gourley
C and Langdon SP: Expression of glycolytic enzymes in ovarian
cancers and evaluation of the glycolytic pathway as a strategy for
ovarian cancer treatment. BMC Cancer. 18:636–651. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Li S, Gao J, Zhuang X, Zhao C, Hou X, Xing
X, Chen C, Liu Q, Liu S and Luo Y: Cyclin G2 Inhibits the Warburg
Effect and Tumour Progression by Suppressing LDHA Phosphorylation
in Glioma. Int J Biol Sci. 15:544–555. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Di H, Zhang X, Guo Y, Shi Y, Fang C, Yuan
Y, Wang J, Shang C, Guo W and Li C: Silencing LDHA inhibits
proliferation, induces apoptosis and increases chemosensitivity to
temozolomide in glioma cells. Oncol Lett. 15:5131–5136.
2018.PubMed/NCBI View Article : Google Scholar
|
